Lifeboat Foundation

Scientists have discovered your cholesterol levels could be significantly linked to your risk of developing dementia. And it’s not just high cholesterol that matters: fluctuating levels over several years could increase your chances of the disease by 60 per cent, suggests a new study of 10,000 people.

The research also suggests that, even if you don’t develop dementia, a large cholesterol variability – swinging from high to low levels – is linked to an increased risk of general cognitive decline by 23 per cent.

And should we — abolish death? Neuroscientist and author Ariel Zeleznikow-Johnston will be speaking at Bush House, King’s College London, on Tues 3rd December, in an event that London Futurists is happy to draw to the attention of all members and friends.

In this event organised by King’s College London, neuroscientist and author Ariel Zeleznikow-Johnston will be speaking about his new book The Future Loves You, which explores how brain preservation techniques might preserve us forever.

Ariel will be in discussion with historians, literary scholars, ethicists, and futurists, including Richard Ashcroft, Steve Connor, Caitjan Gainty, Catriona Byers, and Fay Bound Alberti.

Continue reading “Can we — and should we — abolish death?” »

A series of studies on humans and mice examined sex differences in reactions to anesthetics, revealing that female brains are more resistant to the hypnotic effects of these drugs. Testosterone administration increased sensitivity to anesthetics in mice, while castration enhanced anesthetic resistance. In humans, females regained consciousness and recovered cognitive function faster than males after identical exposure to anesthetics. The study was published in Neuroscience.

General anesthetics are drugs that induce a reversible loss of consciousness, primarily used during surgical procedures to block pain and prevent awareness. They are essential in medicine because they enable complex surgeries that would otherwise be intolerable due to pain, allowing patients to undergo invasive procedures safely and comfortably.

The history of general anesthesia dates back to the 19th century, with the first successful public demonstration by Dr. William Morton in 1846. Before anesthetics, surgery was excruciating and dangerous, often performed only in dire cases due to the severe pain and risks. Over time, safer and more effective agents, such as chloroform and eventually modern inhaled and intravenous anesthetics, were developed. Today, general anesthesia is administered by specialized professionals called anesthesiologists, who monitor and adjust the dosage to ensure patient safety.

Brain-Computer Interfaces fascinate the sci-fi and medical communities in equal measure. Here’s how close the transformative technology is to everyday use.

The idea here is that we can momentarily counteract through movement. It’s compelling.

Natural forms of opiates and dopamine — key players in brain pathways that diminish pain and enhance reward — seem to be telltale ingredients of the elevated tails in our anticipation training program. Observing tail posture in rats adds a new layer to our understanding of rat emotional expression, reminding us that emotions are expressed throughout the entire body.

While we can’t directly ask rats whether they like to drive, we devised a behavioral test to assess their motivation to drive. This time, instead of only giving rats the option of driving to the Froot Loop Tree, they could also make a shorter journey on foot — or paw, in this case.

Continue reading “Neuroscientists taught rats to drive tiny cars. They took them out on ‘joy rides.’” »

Summary: New research has revealed the diverse assembly and regulation of Type-A GABA receptors (GABAARs), which are crucial for balancing brain activity. Using cryogenic electron microscopy, researchers identified over 324,000 potential receptor structures, shaped by subunit combinations and their relative arrangement.

These variations influence receptor function, drug binding, and the brain’s response to stressors like pregnancy or chronic drug use. The findings pave the way for targeted therapies that enhance receptor-specific functions without inducing tolerance or dependence.

Alzheimer’s disease is marked by the gradual degeneration of nerve cells, resulting in memory and cognitive decline. A research team at KU Leuven and VIB investigated the molecular sequence driving this cellular breakdown, discovering specific inhibitors that can prevent nerve cell loss in various mouse models of the disease.

The findings open up new research avenues in the search for therapies that could halt or prevent the accumulation of brain damage occurring in Alzheimer’s.

Alzheimer’s disease, the leading cause of dementia, affects over 55 million people worldwide. The disease is characterized by the buildup of amyloid-beta plaques and tau protein tangles in the brain, which disrupt cell communication and lead to the widespread death of nerve cells. The consequences of this massive cell loss are the heartbreaking cognitive decline and memory loss for which the condition is well known.

Our brains—and specifically, our brain cells—are commonly known to store memories. However, a team of scientists has discovered that cells from other parts of the body also play a role in memory, opening new pathways for understanding how memory functions and creating potential for enhancing learning and treating memory-related conditions.

“Learning and memory are generally associated with brains and brain cells alone, but our study shows that other cells in the body can learn and form memories, too,” explains New York University ’s Nikolay V. Kukushkin, the lead author of the study, which appears in the journal Nature Communications.

Continue reading “Mind-Blowing Discovery: Scientists Discover That Memories Are Not Only in the Brain” »